Filing Flows › Repligen (RGEN) › Who owns the stock
Who owns Repligen (RGEN) stock
462 funds reported Repligen (RGEN) shares in their latest 13F filings, worth $9.5B in all. The largest holder is Vanguard Group ($818M). Last quarter 233 funds added to their stakes and 174 cut them. Members of Congress and other officials disclosed 1 trade (0 buys, 1 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 4,993,945 | $818M | decrease | 2025-12-31 |
| BlackRock | 5,384,938 | $735M | decrease | 2026-06-30 |
| FMR LLC | 3,326,690 | $454M | increase | 2026-06-30 |
| United Capital Financial Advisors, LLC | 2,790,650 | $381M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 2,411,171 | $329M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2,312,825 | $316M | increase | 2026-06-30 |
| Maverick Capital | 1,984,554 | $271M | increase | 2026-06-30 |
| State Street | 1,800,530 | $246M | increase | 2026-06-30 |
| Price T Rowe Associates | 1,752,274 | $239M | decrease | 2026-06-30 |
| Massachusetts Financial Services | 1,617,021 | $221M | increase | 2026-06-30 |
| Ameriprise Financial | 1,576,132 | $215M | increase | 2026-06-30 |
| Bank of New York Mellon | 1,522,859 | $208M | decrease | 2026-06-30 |
| T. Rowe Price Investment Management | 1,411,619 | $193M | increase | 2026-06-30 |
| Invesco | 1,387,242 | $189M | increase | 2026-06-30 |
| Holocene Advisors, LP | 1,292,191 | $176M | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2025-10-31 | Lisa McClain | sale | $1K–$15K |
Repligen's latest quarter
Repligen, Q3 2026: revenue $209M (+11% year over year), operating margin -14.1%, net loss $38.4M, operating cash flow $43.1M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most RGEN stock?
By the latest 13F filings: Vanguard Group ($818M); BlackRock ($735M); FMR LLC ($454M); United Capital Financial Advisors, LLC ($381M); Vanguard Capital Management LLC ($329M).
Has Congress traded RGEN stock?
Officials disclosed 1 trade on file: 0 buys and 1 sales. The latest: Lisa McClain, sale on 2025-10-31.
What is the short interest in RGEN?
7,145,036 shares were sold short at the 2026-10-15 settlement, -5.76% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.